CPR Regeneration Competitors

Scripps Health is a nonprofit integrated healthcare delivery system based in San Diego, Calif. To protect job seekers from online scams, please note that all Scripps Health recruiting activity is conducted exclusively through our official careers website and approved communication channels. We will never ask for banking information, Social Security numbers, payment or other sensitive personal details through LinkedIn messaging. For verified opportunities, please apply directly at https://careers.scripps.org/. Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps treats more than 650,000 patients annually through the dedication of more than 3,500 affiliated physicians and nearly 18,000 employees among its five acute-care hospital campuses, more than 70 outpatient and specialty care locations, and hundreds of affiliated physician offices throughout the region. Scripps is consistently recognized as one of the best places to work in the nation. The Advisory Board, Fortune and Working Mother magazine have all named Scripps a top employer and its hospitals are consistently ranked among the nation's best by U.S. News & World Report. Scripps is committed to attracting and retaining exceptional talent across all disciplines — from clinical care to operations to administration.

Integra LifeSciences is a global medical technology leader dedicated to restoring lives. Headquartered in Princeton, New Jersey, we are advancing transformational care through impactful innovation in neurosurgery and tissue reconstruction, specialized fields that demand exceptional expertise and precision. Our portfolio of highly differentiated gold-standard products and solutions is built on decades of clinical evidence and trusted by healthcare professionals to improve patient outcomes. For the latest news and information about Integra and our products, visit www.integralife.com.

Kerecis was founded by Fertram Sigurjonsson on a simple but unconventional idea: that fish skin can support how the body heals. Today, the company has defined the role of fish‑skin technology in regenerative medicine. By preserving the skin’s natural structure through proprietary processing, it provides a scaffold that supports tissue regeneration. With virtually no risk of viral disease transfer, it is a biologically compatible solution grounded in nature and refined through science. Kerecis products are used to regenerate tissue in a variety of acute, chronic, and surgical applications. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. Kerecis is built around a simple but ambitious vision: to extend human life by enabling the body to regenerate itself. Its mission is to lead the way in tissue repair by sustainably harnessing nature’s own solutions. In August 2023, Kerecis reached a major milestone, becoming Iceland’s first unicorn and joining the Coloplast Group for $1.3 billion.